Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

CytomX Therapeutics (CTMX) Return on Assets (2016 - 2025)

CytomX Therapeutics (CTMX) has disclosed Return on Assets for 11 consecutive years, with 0.17% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Assets rose 8.0% year-over-year to 0.17%, compared with a TTM value of 0.17% through Sep 2025, up 8.0%, and an annual FY2024 reading of 0.2%, up 20.0% over the prior year.
  • Return on Assets was 0.17% for Q3 2025 at CytomX Therapeutics, down from 0.35% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.38% in Q1 2025 and bottomed at 0.52% in Q3 2022.
  • Average Return on Assets over 5 years is 0.11%, with a median of 0.19% recorded in 2023.
  • The sharpest move saw Return on Assets dropped -22bps in 2022, then soared 47bps in 2023.
  • Year by year, Return on Assets stood at 0.28% in 2021, then crashed by -44bps to 0.41% in 2022, then skyrocketed by 99bps to 0.0% in 2023, then soared by 9228bps to 0.25% in 2024, then crashed by -32bps to 0.17% in 2025.
  • Business Quant data shows Return on Assets for CTMX at 0.17% in Q3 2025, 0.35% in Q2 2025, and 0.38% in Q1 2025.